ATE423199T1 - Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik - Google Patents
Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnikInfo
- Publication number
- ATE423199T1 ATE423199T1 AT02743820T AT02743820T ATE423199T1 AT E423199 T1 ATE423199 T1 AT E423199T1 AT 02743820 T AT02743820 T AT 02743820T AT 02743820 T AT02743820 T AT 02743820T AT E423199 T1 ATE423199 T1 AT E423199T1
- Authority
- AT
- Austria
- Prior art keywords
- human thrombin
- prethrombin
- human
- producing human
- thrombin
- Prior art date
Links
- 229960003766 thrombin (human) Drugs 0.000 title abstract 7
- 238000012239 gene modification Methods 0.000 title abstract 3
- 230000005017 genetic modification Effects 0.000 title 1
- 235000013617 genetically modified food Nutrition 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 108010071286 prethrombins Proteins 0.000 abstract 4
- 230000004913 activation Effects 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 238000012258 culturing Methods 0.000 abstract 2
- 108010085662 ecarin Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000011541 reaction mixture Substances 0.000 abstract 2
- 210000004102 animal cell Anatomy 0.000 abstract 1
- 239000006143 cell culture medium Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000002439 hemostatic effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001206919 | 2001-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE423199T1 true ATE423199T1 (de) | 2009-03-15 |
Family
ID=19042979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02743820T ATE423199T1 (de) | 2001-07-06 | 2002-07-04 | Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7635577B2 (de) |
| EP (1) | EP1405910B1 (de) |
| JP (1) | JP4227012B2 (de) |
| KR (2) | KR100983878B1 (de) |
| CN (1) | CN100347297C (de) |
| AT (1) | ATE423199T1 (de) |
| CA (1) | CA2452768C (de) |
| DE (1) | DE60231210D1 (de) |
| WO (1) | WO2003004641A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040219140A1 (en) * | 2001-02-22 | 2004-11-04 | Reiner Class | Compositions and methods for preventing platelet aggregation |
| WO2005010178A1 (ja) | 2003-07-29 | 2005-02-03 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | 組換えフィブリノゲン高産生細胞の作製方法及び高産生細胞 |
| GB0324044D0 (en) * | 2003-10-14 | 2003-11-19 | Astrazeneca Ab | Protein |
| EP2180045B1 (de) | 2003-10-24 | 2015-12-23 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Neuartige rekombinante Tierzellen mit hoher Proteinproduktion, Herstellungsverfahren dafür und Verfahren zur Proteinmassenproduktion damit |
| EP1758640A4 (de) * | 2004-05-24 | 2009-06-03 | Panacos Pharmaceuticals Inc | Hiv-1-replikationshemmung mittels unterbrechung der verarbeitung des viralen capsid-spacer peptid-1-proteins |
| CN101198696B (zh) * | 2005-04-13 | 2014-02-26 | 阿斯利康(瑞典)有限公司 | 包含产生需要γ-羧化的蛋白质用的载体的宿主细胞 |
| AU2006298160A1 (en) | 2005-09-30 | 2007-04-12 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Process for preparing recombinant human thrombin with culture cell |
| WO2007103447A2 (en) * | 2006-03-06 | 2007-09-13 | Humagene, Inc. | A method for the preparation of recombinant human thrombin |
| US8206967B2 (en) | 2007-07-06 | 2012-06-26 | Medimmune Limited | Method for production of recombinant human thrombin |
| JP5437236B2 (ja) | 2008-04-16 | 2014-03-12 | 一般財団法人化学及血清療法研究所 | トロンビン固定化生体吸収性シート製剤の製造方法 |
| EP2940133A4 (de) | 2012-12-25 | 2016-07-06 | Chemo Sero Therapeut Res Inst | Impfstoff für hpv-infektion und/oder hepatitis b mit chimärem hpv/hbs-protein als wirkstoff |
| JP6216647B2 (ja) | 2013-03-15 | 2017-10-18 | シスメックス株式会社 | 組換え型プロトロンビンの製造方法およびその利用 |
| WO2025208342A1 (zh) * | 2024-04-02 | 2025-10-09 | 苏州泽璟生物制药股份有限公司 | 高纯度且低残留的重组人凝血酶制备方法及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2824434B2 (ja) | 1989-11-28 | 1998-11-11 | 財団法人化学及血清療法研究所 | 新規発現ベクター |
| US5278144A (en) | 1990-09-04 | 1994-01-11 | Cor Therapeutics, Inc. | Antithrombosis agents |
| US5583107A (en) | 1990-09-04 | 1996-12-10 | Cor Therapeutics, Inc. | Agents affecting thrombosis and hemostasis |
| CA2078721A1 (en) * | 1991-09-24 | 1993-03-25 | Hiroshi Yonemura | Process for preparing human coagulation factor viii protein complex |
| JP3168087B2 (ja) * | 1993-01-11 | 2001-05-21 | 株式会社ヤスヰ | 洗車方法及びその装置 |
| AT404357B (de) | 1995-06-13 | 1998-11-25 | Immuno Ag | Prothrombin-derivate |
| WO1999058699A2 (en) * | 1998-05-14 | 1999-11-18 | Battelle Memorial Institute | Transgenic plant-derived human blood coagulation factors |
| US6413737B1 (en) * | 1999-07-09 | 2002-07-02 | Cohesion Technologies, Inc. | Ecarin prothrombin protease and methods |
| CN1298017A (zh) * | 1999-11-29 | 2001-06-06 | 中国科学技术大学 | 一种快速活化凝血酶原的方法 |
-
2002
- 2002-07-04 CN CNB028175034A patent/CN100347297C/zh not_active Expired - Fee Related
- 2002-07-04 AT AT02743820T patent/ATE423199T1/de active
- 2002-07-04 EP EP02743820A patent/EP1405910B1/de not_active Expired - Lifetime
- 2002-07-04 JP JP2003510799A patent/JP4227012B2/ja not_active Expired - Fee Related
- 2002-07-04 KR KR1020097015790A patent/KR100983878B1/ko not_active Expired - Fee Related
- 2002-07-04 WO PCT/JP2002/006771 patent/WO2003004641A1/ja not_active Ceased
- 2002-07-04 US US10/482,926 patent/US7635577B2/en not_active Expired - Fee Related
- 2002-07-04 CA CA2452768A patent/CA2452768C/en not_active Expired - Fee Related
- 2002-07-04 KR KR10-2004-7000118A patent/KR20040032147A/ko not_active Ceased
- 2002-07-04 DE DE60231210T patent/DE60231210D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1405910B1 (de) | 2009-02-18 |
| KR20040032147A (ko) | 2004-04-14 |
| US7635577B2 (en) | 2009-12-22 |
| JP4227012B2 (ja) | 2009-02-18 |
| CN100347297C (zh) | 2007-11-07 |
| KR100983878B1 (ko) | 2010-09-27 |
| CN1551917A (zh) | 2004-12-01 |
| EP1405910A4 (de) | 2005-02-02 |
| KR20090087136A (ko) | 2009-08-14 |
| DE60231210D1 (de) | 2009-04-02 |
| CA2452768C (en) | 2011-06-07 |
| US20040197858A1 (en) | 2004-10-07 |
| EP1405910A1 (de) | 2004-04-07 |
| WO2003004641A1 (en) | 2003-01-16 |
| CA2452768A1 (en) | 2003-01-16 |
| JPWO2003004641A1 (ja) | 2004-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE423199T1 (de) | Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik | |
| DE60026142D1 (de) | Verfahren zur herstellung von oligosaccharide | |
| ATE420192T1 (de) | Verfahren zur verringerung der antigenität des adeno-assoziierten virus strukturproteins | |
| ATE346835T1 (de) | Verfahren zur herstellung von acrolein und/oder acrylsäure | |
| WO2008140615A3 (en) | Modified messenger rna stabilizing sequences for expressing genes in bacterial cells | |
| SG161210A1 (en) | Methods for expression and purification of recombinant human growth hormone | |
| DE69634043D1 (de) | Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie | |
| ATE393632T1 (de) | Transfektion von blutzellen mit mrna zur immunstimulation und gentherapie | |
| ATE469223T1 (de) | Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden | |
| ATE334976T1 (de) | Verfahren zur direkten epoxidation unter verwendung eines mischkatalysatorsystems | |
| ATE439437T1 (de) | Verbessertes klonierungsverfahren | |
| RU2008139428A (ru) | Способ получения рекомбинантного тромбина и фибриногена человека | |
| FI943122A0 (fi) | Menetelmiä trombiinin tuottamiseksi | |
| DE60229636D1 (de) | Verfahren zur reinigung von zellen | |
| DE60028777D1 (de) | Verfahren zur herstellung von 1,3-propanediol durch einen rekombinanten micro-organismus in abwesenheit von coenzym b12 | |
| ATE464379T1 (de) | Saatspezifische usp-promotoren zur expression von genen in pflanzen | |
| ATE420868T1 (de) | Verbessertes verfahren zur herstellung von ethylenoxid | |
| ATE542913T1 (de) | Promotorvarianten zur expression von genen in einer pilzzelle | |
| DE60225312D1 (de) | Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen | |
| NL960017I2 (nl) | Expressie van Factor VIII-activiteit in zoogdiercellen. | |
| DE69623122D1 (de) | Methode zur expression in und isolation von biologisch aktiven molekülen aus urin | |
| JPS60500043A (ja) | 原核細胞又は真核細胞中で合成される融合蛋白質から成熟蛋白質を作る方法 | |
| EP1589102A4 (de) | Gensequenz für l-rhamnose-isomerase mit neuer katalytischer funktion und verwendung davon | |
| ATE341630T1 (de) | Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin | |
| DE60318882D1 (de) | Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1405910 Country of ref document: EP |